A valuable approach to the characterization of known and novel autoantigens has used cell component-reactive monoclonal antibodies (mAb) derived from immortalized, in vivo-primed, autoreactive B lymphocytes . For example, in animal systems, murine mAb have been produced from spleen cells of autoimmune inbred mouse strains and used to characterize the autoantigenic structures of Sm (1, 2) and nRNP (3, 4) , as well as DNA (5) (6) (7) (8) (9) (10) (11) (12) and RNA (13) . Similarly, human mAb derived from patients with autoimmune disorders have provided valuable insights into the autoantigenic determinants of the DNA molecule, demonstrating unique and crossreactive features (14) (15) (16) (17) . However, although there have been human mAb generated that are reactive with non-DNA autoantigenic moieties (15, 18) , progress in this area has been considerably slower .
This report describes an autoantibody-producing B cell clone, immortalized from a patient with systemic lupus erythematosus (SLE), that secretes an IgM mAb reactive with DNA and a salt-extractable autoantigen found primarily in the nucleolus. This antigen is no longer bound by the mAb after in situ treatment of the cells with either RNase or trypsin, binds avidly to DEAF-cellulose, and appears to consist of at least two polypeptide chains, of 17 and 18 kD . The following studies suggest that the antigen probably is not related to conventional RNA-associated autoantigens and may represent a novel system . A portion of these studies has been presented previously (19) .
Materials and Methods

Isolation and Activation of Donor Peripheral Blood Mononuclear Cells (PBMC)
Sterile, heparinized venous blood was obtained from a patient (DW) with active, untreated systemic lupus erythematosus (SLE) followed at The Rockefeller University Hospital . This blood was separated into PBMC by centrifugation on a Ficoll-Paque cushion (p 1 .077 ; Pharmacia Fine Chemicals, Piscataway, NJ). PBMC were divided further into T and non-T cell fractions by the neuraminidase-treated sheep erythrocyte rosetting technique (20) . Non-T cells were cultured at a concentration of 2 x 106 cells/ml for 3 .5 d in the presence of fixed Staphylococcus aureus, Cowan strain I (0 .01% final concentration ; Calbiochem-Behring Co ., San Diego, CA) . Before hybridization, viable cells were isolated by another Ficoll-Paque gradient centrifugation step, extractable antigens from rabbit thymus were detected as previously described (25) . The crude soluble antigenic extract was obtained by 0 .15 M NaCI extraction of rabbit thymus acetone powder (RTE) (Pel Freez Biologicals, Rogers, AR) for 3 h at 4°C ; in certain experiments, this crude extract was fractionated by NaCI gradient (0 .05-0 .5 mM) elution from DEAE-cellulose column (DE52 ; Whatman, Inc ., Clifton, NJ) as described (25) .
Fluorescent Antinuclear Antibody (ANA) Assay
Antibodies to cellular antigens were detected by a double sandwich immunofluorescent antibody technique using human HEp-2 cells as the substrate . After 48 h of growth on coverslips, HEp-2 cells were treated with cold 100% methanol for 5 min at -20°C, and then with 0 .5% Triton X-100 in PBS for 1 min at room temperature . The fixed, permeabilized cells were incubated with fresh culture medium for 2 h at room temperature, washed, and reacted for 18 h with cell culture supernatants containing various human monoclonal antibodies or with serum containing reference autoantibodies. After three washes with fresh medium, cells were exposed to 40 jug/ml of affinity-purified rabbit anti-human Ig antibodies for 1 h at room temperature . Subsequently, cells were washed three times and then reacted with an FITC-labeled goat anti-rabbit antibody preparation 'Abbreviations used in this paper: ANA, antinuclear antibody ; DRB, 5,6-dichloro-l-,B-ribofuranosylbenzimidazole ; dsDNA, double-stranded DNA ; ENA, extractable nuclear antigen; HGPRT, hypoxanthine/guanine phosphoribosyl transferase ; RTE, rabbit thymus extract ; ssDNA, singlestranded DNA .
that had been preabsorbed to remove reactivity with cellular constituents (the gift of Dr. E. Wang of The Rockefeller University) .
Antibodies reactive with native DNA were detected by indirect immunofluorescence using fixed Crithidia luciliae organisms (AnDNA FluoroKit II; Clinical Sciences Inc ., Whippany, NJ) according to the directions of the manufacturer .
Rabbit antibodies reactive with mammalian RNA polymerase I were kindly provided by Dr. Kathleen Rose of The University of Texas Health Science Center at Houston . Indirect immunofluorescent assays were performed with these antibodies and a rhodamine-conjugated preparation of goat antibodies to rabbit Ig (Tago, Inc .) .
Treatment of HEp-2 Cells with 5,6-Dichloro-1-,Q-ribofuranosylbenzimidazole (DRB), Actinomycin D, DNase or RNase, and Trypsin DRB and actinomycin D were purchased from Calbiochem-Behring Co . For studies using these compounds, HEp-2 cells were cultured for 48 h at 37°C in 5% C02 atmosphere and then incubated with either DRB, at concentrations of 25, 5, or 1 ug/ml for 6 h, or with actinomycin D, at concentrations of 5 .0, 0 .5, and 0.05 ug/ml for 2 h. Under the conditions described, the addition of these compounds did not grossly alter the growth characteristics or cell viability of the HEp-2 cells. At the end of the incubation periods, cells were washed, fixed, and then used for the ANA assay .
Deoxyribonuclease I (DNase) and pancreatic ribonuclease A (RNase) were purchased from Sigma Chemical Co . DNase contaminating the RNase preparation was inactivated by heating as described (26) . In certain experiments, HEp-2 cells were treated for 30 min at 22°C with 50 1Al of 50 ug/ml of either DNase or RNase in phosphate-buffered saline before staining with various antibody preparations (27) .
Immunoprecipitation and SDS-PAGE Analysis of 3 'S-labeled Cellular Antigens
The human m eloid cell line, K562, was cultured for 16 h at 37°C at a concentration of 4 x 106 cells~ml in methionine-deficient RPMI 1640 medium containing 50 pCi of I 3SSJmethionine (-1,100 Ci/mmol ; New England Nuclear, Boston, MA), and 10% dialyzed FCS . A cell extract was prepared and immunoprecipitations were performed with human autoimmune sera as described (28) . A modification of this procedure was used for immunoprecipitations with human mAb-containing supernatants. For immunoprecipitations, 5-10 ml of culture supernatant containing the appropriate mAb or 10 gl of patient serum was rotated with the extract of 10 6 cells for 14 h at VC .
C. The immune complexes were reacted for 2 h at 4°C with protein A-Sepharose beads (Pharmacia Fine Chemicals) that had been coated for 16 h with affinity-purified rabbit anti-human Ig antibodies . The immunoprecipitates were washed and proteins were eluted by boiling for 5 min in 0.25 M sucrose, 2 .5% SDS, 0.1 M Tris, pH 7 .5, 5 .0 mM EDTA, 0.1 M dithiothreitol, 0 .005% bromphenol blue, followed by analysis on 12 .5 or 15% SDS-polyacrylamide gels. The gels were stained with Coomassie blue, destained, and fluorographed as previously described (29) .
Results
Patient Description . The cell lines described in this report were derived using the peripheral blood B lymphocytes of a 15-yr-old black woman followed at The Rockefeller University Hospital for SLE . The patient had a 3-yr history of intermittent high fevers, joint pains and swelling, oral ulcers, and occasional mild proteinuria . Pertinent laboratory data included erythrocyte sedimentation rate 32 mm/h, hemoglobin, 9.1 gm%, white blood cell count, 2,800 with a normal differential count, total serum protein, 8.6 g/dl, with an elevated serum IgG, 2,600 mg% (nl < 1,800) .
The patient's serum contained ANA at a dilution of 1 :1,280, with bright, homogeneous immunofluorescent staining of the nucleoli, granular staining of the nucleoplasm, and weak cytoplasmic fluorescence (Fig. 1 ). Solid-phase enzyme immunoassay and fluid-phase Farr radioimmunoassay revealed significant serum antibody binding to heat-denatured (1 :30,000 and 1 :1,000, respectively) and native (1 :6,000 and 1 :250, respectively) DNA. Antibodies to native DNA were confirmed in a Crithidia luciliae immunofluorescent assay that showed characteristic staining of kinetoplasts at a serum dilution of 1 :640. In addition, antibodies to the battery of ENA contained in RTE were detected by ELISA (1 :2,500); these antibodies reacted in hemagglutination assay (30) with antigenic sites that were sensitive to RNase digestion, which were found subsequently to be distinct from the nRNP determinants . Finally, serum autoantibodies reactive with Ro/SSA and Ku (p70/p80) antigens also were detected by immunoprecipitation of radiolabeled cellular RNA or proteins, respectively .
Generation of Human B Cell Lines Reactive with Autoantigens. B lymphocytes isolated from the peripheral blood of this patient were activated for 4 d by 0.01 formalinized Staphylococcus aureus, Cowan strain 1 (protein A-positive) organisms and then fused, in the presence of polyethylene glycol, with the HGPRT-deficient variant human B cell line 0467.3 . After 3 wk of selection in HAT medium, 97 growth-positive wells were obtained and tested for production of human Ig and for reactivity with various autoantigens . Table I lists a series of monoclonal antibodies secreted by certain of these 97 hybridomas and the parental cell line (0467.3) and their reactivities with singlestranded DNA (ssDNA), double-stranded DNA (dsDNA), and a crude ENA preparation. 36 of the 97 growth-positive cultures produced human IgM mAb reactive with either native and/or ssDNA, although reactivity with the latter was usually more intense. Initially, two cultures, W8 and W99, were found also to react in ELISA with ENA (Table I) . However, after several more weeks of culture, only the W8 cell line continued to secrete an mAb reactive with both DNA and ENA. This cell line has now been cultured intermittently for over 3 yr without loss of reactivity . The property of dual DNA and RTE reactivity by the mAb has not been altered by continued culture or by limiting-dilution cloning of the cell line (data not shown) . The W8 human mAb next was tested for its reactivity with fixed HEp-2 cells and with Crithidia luciliae organisms in indirect immunofluorescent assays . Strong staining of HEp-2 cell nucleoli was demonstrated ( Fig. 2A) , whereas nucleoplasmic immunofluorescence was negligible, and cytoplasmic reactivity minimal. When present, cytoplasmic staining varied from preparation to preparation and within certain cells of an individual fixed-cell preparation. Reactivity with Crithidia kinetoplasts was not detected, even after overnight incubation with the mAb.
Thus, the staining patterns and the ELISA binding data of the W8 mAb were similar to those mentioned above for a portion of the polyclonal antibodies from the original SLE donor's serum, i.e., reactivity with both single-stranded DNA and an extractable nuclear antigen in solid-phase enzyme immunoassay and with nucleoli by immunofluorescent assay.
Partial Characterization of the Autoantigen(s) Bound by the W8 mAb. In an attempt to define the molecular characteristics of the antigen(s) recognized by the W8 mAb, fixed HEp-2 cells were treated with either DNase, RNase, or trypsin before staining with the mAb (Fig. 2) . Fig. 2 A illustrates the typical nucleolar staining pattern of the HEp-2 cells without enzyme digestion. Pretreatment of the cells with DNase failed to alter W8 binding to the nucleolus (Fig.  2 B) . However, pretreatment of the HEp-2 cells with RNase ( Fig. 2 C) tioned above, the extractable nuclear antigens in the RTE preparation, with which the patient's serum autoantibodies reacted, had been shown previously to be RNase sensitive. As was the case for the W8 mAb, the nucleolar staining of the serum autoantibodies similarly was found to disappear with RNase digestion of the HEp-2 cells (not shown) . Because the nucleolus is transcriptionally highly active, attempts were made to determine if the antigen bound by W8 was involved in ribosomal RNA synthesis and possibly associated with the transcriptional units of the ribosome. This was evaluated by using the two antimetabolites, DRB and actinomycin D. DRB has been shown to cause nucleolar dispersal or fragmentation while inhibiting messenger but not ribosomal RNA transcription (31, 32) . Appropriate doses of actinomycin D suppress ribosomal RNA synthesis without causing nucleolar dispersal (33) .
When HEp-2 cells were incubated with DRB for 6 h and then stained with the W8 mAb, the usual intact nucleolar pattern was replaced by a series of distinct immunofluorescent dots (Fig. 3 B) . 2 h of actinomycin D treatment resulted in a more dense condensation of the nucleolus, without an alteration of immunofluorescent staining (not shown) .
Studies by others (34) have demonstrated that antibodies to RNA polymerase I stain the DRB-dispersed nucleolus in a pattern characteristic of the "necklaces" seen when DRB induces unraveling of the nucleolus (31). Since RNA polymerase I has been shown to be the target of autoantibodies in certain autoimmune conditions (35) , an experiment was performed to compare the immunofluorescent staining pattern of rabbit antibodies against RNA polymerase I (36) with that of the human mAb W8. This was done by indirect immunofluorescence using a rhodamine-conjugated goat anti-rabbit antibody preparation and a fluorescein-conjugated goat anti-human antibody preparation. As depicted in Fig. 4 , the rabbit antibodies to RNA polymerase I gave the typical, distinctive necklace immunofluorescent configuration (Fig. 4A) , whereas staining of the same cell with the W8 mAb (Fig. 4B ) yielded large dot-like staining that did not appear to colocalize with the smaller dots of the anti-RNA polymerase I necklace .
Comparison of the W8-extractable Nuclear Antigen with Other Known Autoantigens . The antigenic specificity recognized by the W8 mAb was compared with other previously defined reactivities in two ways. First, the extractable nuclear antigens contained in the rabbit thymus extract were subfractionated by anionexchange chromatography and the fractions were reacted with the mAb or control serum antibodies . Because the W8 mAb recognized an extractable nuclear antigen, anti-Sm and anti-RNP autoantibodies, the first described ENA systems (37, 38) , were used as reference antibodies . Fig. 5 illustrates the pattern of binding of (a) polyclonal anti-Sm or anti-RNP reference antibodies, (b) the patient's serum and, (c) the W8 mAb to discrete fractions of RTE that were isolated by gradient (50-500 mM) NaCl elution of the RTE from a DE-52 column. As shown in Fig. 5A , anti-Sm antibodies bind to multiple fractions of RTE eluted from the anion-exchange column ; these fall into three broad peaks (1, 11, I11 ). In contrast, anti-RNP antibodies bind only those fractions in peak 11 . However, as illustrated in Fig. 5 , B and C, the patient's serum antibodies and the W8 mAb, respectively, do not show binding patterns analogous to those observed with the anti-Sm or RNP reference autoantibodies. Rather, these antibodies bind with increasing avidity to the more highly negatively charged RTE protein fractions, suggesting that the patient's serum antibodies and the W8 mAb are interacting with acidic residues which are capable of binding relatively tightly to the anion exchanger, and which are distinct from the Sm and RNP autoantigens .
A more direct comparison between the structure of the W8 antigen and other known autoantigens was made by SDS-PAGE analysis of [s5S]methionine-labeled cell extracts of K562 cells immunoprecipitated by either : (a) W8, (b) the mAb from the parental fusion partner, 0467.3, (c) mAb W9 (another DNA-reactive human mAb derived from the same fusion as W8), (d) normal human serum, (e) the original patient's serum, and (f) serum from a patient with known anti-Sm antibodies (Fig. 6) .
As shown previously (39), the anti-Sm serum (Fig. 6, A and B) immunoprecipitated eight major bands with molecular masses ranging from 32 to 9 kD. HEp-2 cells were grown for 48 h on glass coverslips, washed, and then cultured for another 6 h in DRB (25,ug/ml) . Rabbit antibodies to RNA polymerase I were incubated for 1 h, washed, and then counterstained with rhodamine-conjugated goat anti-rabbit antibodies at 40 wg/ml ; human mAb W8 was incubated with fixed HEp-2 cells overnight at 4°C and then counterstained with FITC-conjugated goat anti-human antibodies at 40 kg/ml . A and B represent the same cell nucleus stained with these two antibody systems . Original magnification x 900 .
However, as shown, the W8 mAb immunoprecipitated two major bands with molecular masses of 17 and 18 kD; bands in the 32-50 kD range also were identified, although their appearance varied from experiment to experiment and their significance is unclear at this time. Culture supernatant from the parental , and the W8 mAb (C), to isolated fractions of RTE. RTE fractions were prepared as described (25) by eluting the crude, bound antigens from a DE-52 column with a 200 ml linear gradient of 50-500 mM NaCl in 10 mM sodium phosphate (pH 7.5). 50-jut samples of individual fractions were then bound to enzyme immunoassay plate wells and reacted with the various antibody preparations. Absorbance at 492 nm of each fraction is shown.
0467 .3 cell line and from the W9 culture (Fig. 6A) failed to immunoprecipitate the 17 and 18 kD bands, even after prolonged autoradiographic exposure. Fig . 6B demonstrates that the patient's serum antibodies immunoprecipitated several proteins, including two proteins with molecular masses similar to those immunoprecipitated by the W8 mAb (Fig. 6B, Pt serum) , indicating that the patient's serum autoantibodies and the mAb recognize the same proteins. In other experiments, immunoprecipitation analyses of [s2P]orthophosphoric acidlabeled cell extracts failed to demonstrate coprecipitation of labeled nucleolar RNA species including U3, 8-2, and 7-2 . RNAs (data not shown).
Discussion
A human B cell line (W8) was derived that secretes an IgM mAb reactive with DNA and an ENA in enzyme immunoassay, and with nucleoli in a fluorescent ANA assay . This multiple reactivity was a function of a single antibody from a single immortalized B cell; prolonged culture and limiting-dilution cloning procedures failed to alter the data . The non-DNA antigenic moiety recognized by the W8 mAb was expressed in the nucleolus of HEp-2 cells grown for 48 h in vitro, and was sensitive to in situ enzymatic digestion with trypsin and RNase, but not DNase (Fig. 2) . In addition, this mAb bound to proteins that required a high concentration of salt for displacement from a DEAE-cellulose column (Fig.  5) , and therefore probably represent molecules with high concentrations of negative charge . Several other autoantigens are known to be negatively charged, either because of the presence of acidic residues on the protein moieties themselves or because of the intimate association of small RNA molecules with the protein moieties (40, 41) . However, attempts to determine if the latter is .the case for the antigen recognized by the W8 mAb have been inconclusive (see below) .
In addition, attempts were made to determine whether the nucleolar antigen recognized by W8 was associated with the active transcriptional units of the nucleolus. For these experiments, the halogenated ribofuranosylbenzimidazole, DRB, was used to unravel the bound nucleolus into "nucleolar necklaces" (31) , which others have suggested correspond to linear arrays of active ribosomal RNA genes and transcriptional units (34, 42) . In DRB-treated HEp-2 cells, the W8 mAb appears to bind large dot-like fragments released from the nucleolus (Fig. 3B) . However, it is unlikely that WS binds to intact RNA polymerase I or to active transcriptional units, because the characteristic necklace configuration of immunofluorescence seen with antibodies to RNA polymerase I (Fig. 4A) was not visualized (Fig. 4B ) in DRB-treated cells. This lack of colocalization of RNA polymerase I and W8 staining, after DRB treatment, is similar to that shown previously (34) for the S1 antigen, a protein that is present in preribosomal particles and is randomly distributed throughout the nucleus after drug exposure . It is possible that the W8 antigen, like S1, is not an epitope of the transcriptional machinery but of transcriptional products, which are dispersed separately into the cell nucleus after DRB exposure (34) . In addition, treatment of the HEp-2 cells with actinomycin D resulted in further condensation of the nucleolus and persistent immunofluorescent staining with the W8 mAb, indicating that the antigen is still expressed when ribosomal RNA synthesis is inhibited, a finding that further distinguishes the antigen bound by W8 from RNA polymerase I. Thus the W8 antigen appears to be a NaCl-extractable protein or ribonucleoprotein with acidic domains that is localized primarily in the nucleolus of HEp-2 cells but is distinct from those antigens associated with the transcriptional units of active ribosomal RNA genes.
Immunoprecipitation and SDS-PAGE analyses of [s5S]methionine-labeled cellular proteins have provided preliminary information regarding the molecular nature of the proteins bound by the W8 mAb . The W8 mAb immunoprecipitated at least two polypeptides with molecular masses of 17 and 18 kD (Fig. 6 ). Higher molecular mass bands ranging from^-35 to 50 kD have appeared at times in W8 immunoprecipitates ; the present studies cannot rule out the possibility that certain of these proteins may be immunoprecipitated specifically or are coprecipitated by the W8 mAb . This is relevant because recent studies (43, 44) have demonstrated that certain SLE sera contain autoantibodies to ribosomal proteins of 38, 19, and 17 kD when analyzed by SDS-PAGE and western blotting of isolated ribosomal proteins. These proteins (PO, P1, P2) appear to be analogous to those described in lower eukaryotic species, yeast, and bacteria (45, 46) , and are acidic molecules that are part of a soluble protein-nucleic acid complex (44) . Because the W8 antigen also is an RNase-sensitive, acidic protein composed of at least two chains of 17 and 18 kD, the W8 and P systems may be related . Although this possibility requires further evaluation, there is evidence that this may not be the case. First, the W8 antigen is localized primarily to the nucleolus in 48-h cultures of HEp-2 cells, whereas the P proteins are detected by SLE serum antibodies primarily in the cytoplasm (44, (47) (48) (49) (50) . Second, the molecular masses of these two sets of proteins, albeit similar, are not identical . In this regard, it should be noted that a murine mAb, prepared against isolated nucleoli and reactive with cytoplasmic P proteins, has reactivity with a nucleolar, monomeric (^"38 kD) form of the PI/P2 proteins (51) . Finally, western blotting analysis of the reactivity of the W8 mAb and the original patient's serum antibodies with isolated ribosomal proteins failed to demonstrate reactivity of either set of antibodies with the P proteins, although some reactivity of the patient's IgM serum antibodies with other ribosomal proteins was noted (K. Elkon, unpublished observations) . Further studies will be necessary to determine if the W8 antigen represents a distinct antigenic system or rather a nucleolar processing variant of the cytoplasmic P proteins.
Whereas the initial characterization of the protein moieties recognized by the W8 mAb has been helpful, attempts to define a s2P-labeled RNA species attached to the W8 proteins have been unsuccessful to date. Although the bulk ofnucleolar RNA is preribosomal and ribosomal RNA, certain small nuclear species, in particular U3, 7-1, 7-2, and 8 S RNAs accumulate in the nucleolus in association with pre-ribosomal RNA and ribosomal RNA . Previous studies have suggested the existence of autoantibodies that coprecipitate U3 (37), or 7-2 and 8-2 (52, 53) , nucleolar small RNAs. The protein moieties of these small nucleolar ribonucleoproteins, which by analogy with other ANA systems are probably the targets of the autoantibodies, have not been identified to date. However, it seems unlikely that the antigen recognized by the W8 mAb is a component of these three types of smaller nucleolar ribonucleoproteins because U3, 7-2, and 8-2 S RNAs were not coprecipitated by the mAb or by the patient's serum, while in the same experiment, reference antibodies to To/Th (52, 53) coprecipitated 7-2 and 8-2 RNA (data not shown) . The reason(s) for these negative data are not yet clear. One possibility is that the antigen recognized by the mAb binds to a large RNA species (e.g., rRNA precursor) that is not efficiently immunoprecipitated, as has been noted in other systems (54) . A second possibility is that the mAb recognizes a conformational determinant formed by protein and nucleic acid moieties that are in close proximity within the nucleolus but not permanently associated ; in such a situation the noncovalently linked complex might not immunoprecipitate well. Finally, the affinity of the IgM W8 mAb may be involved. In this regard, our studies (55) and those of others (14, 17) have shown that human IgM mAb that react with DNA and other cellular constituents are frequently of low antigen-binding activity and therefore may be difficult to use for immunoprecipitation analyses. Studies to distinguish between these possibilities are in progress.
The multiple antigenic reactivities of the W8 mAb are notable. This IgM mAb binds quite well to ssDNA and the nucleolar ENA described above. The phenomenon of dual reactivity of an mAb with DNA and other cellular structures has been reported previously (55) (56) (57) (58) . In humans, IgM mAb reactive with DNA have been shown to also bind to and immunoprecipitate the intermediate filament, vimentin (56); in mice, an mAb has been reported that is reactive with DNA and Sm (58) . The frequency at which the W8 and other crossreactive antibody specificities occur in the SLE population is unclear at this time. However, a retrospective review of SDS-PAGE analyses of labeled cellular proteins immunoprecipitated by a panel of SLE sera suggest that the W8 specificity is not common.
Finally, if the W8 hybridoma cell is an immortalization of an autoantibodyproducing clone, as our data would suggest, then it is intriguing to postulate that the apparently distinct serum autoantibody populations directed at ssDNA, ENA, and nucleoli are actually the manifestation of the same antibody population that is represented by the W8 mAb. This hypothesis is currently under investigation . In any event, it is clear that human mAb obtained by immortalization of autoreactive B cells are valuable probes for examining autoantigenic structures shared by different molecules, such as nucleic acids and proteins . The multiple reactivities displayed by the W8 and other such mAb might be illustrative of the reactivities of other naturally occurring autoantibodies seen in normal and diseased individuals. Summary B lymphocytes from a patient with systemic lupus erythematosus (SLE) and several circulating autoantibodies (including antinucleolar antibodies) were immortalized by fusion with a hypoxanthine/guanine phosphoribosyl transferase (HGPRT)-deficient human B cell line . Multiple human monoclonal antibodies (mAb) were obtained which, in solid-phase enzyme immunoassay, were reactive with DNA. One mAb was of special interest because it reacted strongly with both single-stranded DNA and an extractable nuclear antigen found in rabbit thymus extract (RTE). In an immunofluorescent assay using fixed human cells, the latter mAb also bound predominantly to cell nucleoli . A combination of enzyme digestion and metabolic inhibitor studies of the target cells in this immunofluorescent assay suggested that the antigen(s) bound by the mAb was an RNA-associated protein or a ribonucleoprotein that is distinct from intact RNA polymerase I and not associated with the transcriptional units of the nucleolus. In other experiments, using fractions of RTE isolated by ion-exchange chromatography, the antigens bound by the mAb were shown to be highly negatively charged molecules. Immunoprecipitation and SDS-PAGE analyses of labeled cell extracts bound by the mAb revealed a doublet of 17 and 18 kD .
Since the original patient's serum autoantibodies also bound to both an RNasesensitive, acidic, extractable nuclear antigen and to nucleoli, and immunoprecipitated proteins of similar molecular masses in SDS-PAGE, it appears that the described mAb is a product of an immortalized autoantibody-producing B cell clone from the SLE patient's peripheral blood. This mAb probably defines a novel RNA-associated autoantigen residing predominantly in the nucleolus or, less likely, a variant of either RNA polymerase I or the ribosomal autoantigens (P proteins) .
